Login / Signup
Role of transarterial chemoembolization for hepatocellular carcinoma with extrahepatic metastases in the era of advancing systemic therapy.
Byeong Geun Song
Myung Ji Goh
Wonseok Kang
Dong Hyun Sinn
Geum-Youn Gwak
Yong-Han Paik
Joon Hyeok Lee
Moon Seok Choi
Published in:
Journal of liver cancer (2024)
In patients with HCC and EHM, TACE can provide a survival benefit comparable to that of newer systemic therapies. Accordingly, TACE remains a valuable option in this era of new systemic therapies.
Keyphrases
</>
radiofrequency ablation
stem cells
drug induced
bone marrow
cell therapy
free survival